Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Liver cancer
Closed
Phase 3
This trial is looking at a treatment called radioembolisation before starting a drug called sorafenib for liver cancer. It is for people who have a type of liver cancer called hepatocellular carcinoma that can’t be removed with surgery.
Recruitment start: 20 April 2015
Recruitment end: 5 September 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Meyer
Biocompatibles UK Limited
BTG International Ltd
Last reviewed: 08 Jan 2018
CRUK internal database number: 12841